Millennium Management
THRD

Millennium Management’s Third Harmonic Bio THRD Stock Holding History

Millennium Management’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-59,360
Closed -$322K – 6471
2025
Q2 		$322K Buy
59,360
+7,832
+15% +$39.1K ﹤0.01% 5159
2025
Q1 		$179K Sell
51,528
-588,556
-92% -$2.85M ﹤0.01% 5331
2024
Q4 		$6.59M Buy
640,084
+558,616
+686% +$6.96M ﹤0.01% 2574
2024
Q3 		$1.1M Sell
81,468
-20,460
-20% -$253K ﹤0.01% 4191
2024
Q2 		$1.33M Sell
101,928
-153,365
-60% -$1.9M ﹤0.01% 3883
2024
Q1 		$2.41M Buy
+255,293
New +$2.48M ﹤0.01% 3568
2023
Q1 		– Sell
-271,255
Closed -$1.17M – 6859
2022
Q4 		$1.17M Buy
271,255
+92,954
+52% +$1.56M ﹤0.01% 4012
2022
Q3 		$3.38M Buy
+178,301
New +$3.21M ﹤0.01% 3262

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AB
Amalgamated Bank New York $13.1B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Millennium Management's THRD Position: Q3 2025 in Review

Millennium Management sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 59,360 shares — an estimated $322K sold.

Millennium Management first reported a position in THRD in Q3 2022 and held it in 8 quarters. The position peaked at $6.59M in Q4 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Millennium Management reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Millennium Management sold 59,360 Third Harmonic Bio shares in Q3 2025, an estimated $322K.
  • Millennium Management first reported a position in Third Harmonic Bio in Q3 2022 and held it in 8 quarters.
  • Millennium Management's Third Harmonic Bio position peaked at $6.59M in Q4 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.